Latest News about MOR
Recent news which mentions MOR
From Benzinga
 From Benzinga
 From Benzinga
 
   12 Health Care Stocks Moving In Tuesday's Pre-Market Session
   
  
  
  March 22, 2022
  From Benzinga
 From InvestorPlace
 
   Earnings Scheduled For March 16, 2022
   
  
  
  March 16, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Friday
   
  
  
  February 18, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Thursday
   
  
  
  February 17, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022
   
  
  
  January 14, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Pre-Market Session
   
  
  
  January 06, 2022
  From Benzinga
 
   20 Stocks Moving in Wednesday's Pre-Market Session
   
  
  
  December 22, 2021
  From Benzinga
 
   12 Health Care Stocks Moving In Friday's Pre-Market Session
   
  
  
  December 10, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
   
  
  
  December 06, 2021
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  November 22, 2021
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Pre-Market Session
   
  
  
  November 11, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
   
  
  
  November 10, 2021
  From Benzinga
 From Benzinga
 
   The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
   
  
  
  October 21, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
   
  
  
  October 08, 2021
  From Benzinga
 From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Pre-Market Session
   
  
  
  October 07, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
   
  
  
  October 01, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
   
  
  
  September 17, 2021
  From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
